Dr. Amy Jenkins joined DARPA as a program manager in the Biological Technologies Office (BTO) in June 2019. Her interests include the development of platforms for combatting infectious disease threats as well as novel manufacturing methods to enable rapid response.
Prior to joining DARPA, Jenkins was a senior scientist at Gryphon Technologies, where she contributed to development of programs targeting infectious disease threats within BTO. Previously, Jenkins studied the virulence factors of, and antibodies targeting, multi-drug resistant bacterial pathogens at Me mune. She also served as a National Research Council postdoctoral fellow at the U.S. Army Medical Research Institute of Infectious Diseases, where she studied virulence mechanisms of biodefense pathogens.
Jenkins received her Doctor of Philosophy in chemistry and chemical biology from Cornell University and her Bachelor of Science in chemistry and biomolecular science from Clarkson University.
All times are presented in the host university’s local time zone.
Preparing for Pandemic Threats in a Rapidly Changing World
(9:35am - 10:20am)